These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27787959)

  • 1. Cytologic persistence of malignant cells after transurethral resection of bladder tumors: Implications for concomitant manipulation of the urinary tract at the time of endoscopic resection.
    Macleod LC; Pham KN; Agoff SN; Dahl KL; Pritchett TR; Corman JM
    Cancer Cytopathol; 2017 Feb; 125(2):114-119. PubMed ID: 27787959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative bladder washing cytology after transurethral resection. Can it predict the recurrence of urothelial carcinoma?
    Iczkowski KA; Katz G; Cascione CJ
    Acta Cytol; 2004; 48(3):380-4. PubMed ID: 15192954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.
    Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B
    Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer.
    Vanneste M; van der Heij B; Christiaansen CE; Berendsen CL; Driessen EJM; Bruins HM
    World J Urol; 2023 Aug; 41(8):2173-2178. PubMed ID: 37328699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence.
    Hu Z; Mudaliar K; Quek ML; Paner GP; Barkan GA
    Ann Diagn Pathol; 2014 Apr; 18(2):49-52. PubMed ID: 24370460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time between first and second transurethral resection of bladder tumors in patients with high-grade T1 tumors: is it a risk factor for residual tumor detection?
    Süer E; Özcan C; Baltacı S; Gülpınar Ö; Burgu B; Haliloğlu A; Bedük Y
    Urol Int; 2013; 91(2):182-6. PubMed ID: 23751593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.
    Kim DH; Choi MS; Choi JH; Lee C; Jeh SU; Kam SC; Hwa JS; Hyun JS; Choi SM
    Investig Clin Urol; 2024 May; 65(3):279-285. PubMed ID: 38714518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of preoperative urinary smear test in patients with bladder urothelial carcinoma in a high-volume center.
    Restrepo-Gonzalez JA; Garcia-Perdomo HA; Varela R
    Arch Esp Urol; 2014 Apr; 67(3):243-8. PubMed ID: 24840589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
    Richterstetter M; Wullich B; Amann K; Haeberle L; Engehausen DG; Goebell PJ; Krause FS
    BJU Int; 2012 Jul; 110(2 Pt 2):E76-9. PubMed ID: 22313727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer].
    Chen JC; Li T; Ning XH; Peng SH; Wang JY; Qi NN; Cai L; Gong K
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1124-7. PubMed ID: 27095782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.
    Fujita N; Hatakeyama S; Okita K; Momota M; Tobisawa Y; Yoneyama T; Yamamoto H; Imai A; Ito H; Yoneyama T; Hashimoto Y; Yoshikawa K; Ohyama C
    Urol Oncol; 2021 Jan; 39(1):75.e9-75.e16. PubMed ID: 32665123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
    Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
    Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours.
    Struck JP; Ozimek T; Schnoor M; Offermann A; Guenther M; Roesch MC; Wießmeye JR; Katalinic A; Perner S; Borgmann H; Merseburger AS; Kramer MW
    Urol Int; 2023; 107(8):792-800. PubMed ID: 37497994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
    Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
    Sadek S; Soloway MS; Hook S; Civantos F
    J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer.
    Liu H; Wu J; Xue S; Zhang Q; Ruan Y; Sun X; Xia S
    J Int Med Res; 2013 Aug; 41(4):984-92. PubMed ID: 23760914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy.
    Dwivedi US; Kumar A; Das SK; Trivedi S; Kumar M; Sunder S; Singh PB
    Urol Oncol; 2009; 27(5):514-9. PubMed ID: 18639472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.